APA (7th ed.) Citation

Volkman, H. R., de Munter, L., Nguyen, J. L., Tran, T. M. P., Mitratza, M., Marques, C., . . . Otero-Romero, S. (2026). Durability of the BNT162b2 XBB: 1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform. PLoS ONE, 21(2), 1. https://doi.org/10.1371/journal.pone.0342382

Chicago Style (17th ed.) Citation

Volkman, Hannah R., et al. "Durability of the BNT162b2 XBB: 1.5-adapted Vaccine Against JN.1 Hospitalisation in Europe, October 2023 to August 2024: A Test-negative Case-control Study Using the Id.DRIVE Platform." PLoS ONE 21, no. 2 (2026): 1. https://doi.org/10.1371/journal.pone.0342382.

MLA (9th ed.) Citation

Volkman, Hannah R., et al. "Durability of the BNT162b2 XBB: 1.5-adapted Vaccine Against JN.1 Hospitalisation in Europe, October 2023 to August 2024: A Test-negative Case-control Study Using the Id.DRIVE Platform." PLoS ONE, vol. 21, no. 2, 2026, p. 1, https://doi.org/10.1371/journal.pone.0342382.